BRIDGEWAY CAPITAL MANAGEMENT, LLC - WEREWOLF THERAPEUTICS INC ownership

WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 38 filers reported holding WEREWOLF THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$204,394
-21.6%
95,511
+11.7%
0.01%
-16.7%
Q2 2023$260,809
+22.8%
85,511
+4.7%
0.01%0.0%
Q1 2023$212,449
+26.8%
81,7110.0%0.01%
+50.0%
Q4 2022$167,508
-10.9%
81,711
+95.9%
0.00%
-20.0%
Q3 2022$188,000
+27.0%
41,711
+15.2%
0.01%
+66.7%
Q2 2022$148,00036,2110.00%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DC Funds, LP 589,102$10,274,00048.81%
MPM ASSET MANAGEMENT LLC 4,284,172$74,716,00013.89%
MPM BioImpact LLC 2,388,011$41,647,0006.84%
Soleus Capital Management, L.P. 563,396$9,826,0001.51%
RA Capital Management 4,291,881$74,850,0001.20%
SPHERA FUNDS MANAGEMENT LTD. 706,294$12,049,0000.82%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,552,787$44,521,0000.79%
Nicholas Investment Partners, LP 294,654$5,139,0000.32%
Avidity Partners Management LP 650,265$11,341,0000.31%
PFM Health Sciences, LP 400,000$6,976,0000.22%
View complete list of WEREWOLF THERAPEUTICS INC shareholders